Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Equillium (0A4D) vs. Competitors

2 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
GB:0A4DEquillium$1.30$83.70M-7.3246.73%Strong BuyUnlock the GB:0A4D analyst price target with TipRanks PremiumGB:0A4DUnlock the GB:0A4D top-analyst price target with TipRanks Premium
NRXPNRX Pharmaceuticals$2.19$99.51M-2.95-15.44%Strong BuyUnlock the NRXP analyst price target with TipRanks PremiumGB:0A4D vs NRXPUnlock the NRXP top-analyst price target with TipRanks Premium
STROSutro Biopharma$9.82$159.01M-0.785.71%Strong BuyUnlock the STRO analyst price target with TipRanks PremiumGB:0A4D vs STROUnlock the STRO top-analyst price target with TipRanks Premium
HYFTMindWalk Holdings$0.99$47.57M-3.87-40.00%Strong BuyUnlock the HYFT analyst price target with TipRanks PremiumGB:0A4D vs HYFTUnlock the HYFT top-analyst price target with TipRanks Premium
PRLDPrelude Therapeutics$3.45$280.91M-4.37128.48%Moderate BuyUnlock the PRLD analyst price target with TipRanks PremiumGB:0A4D vs PRLDUnlock the PRLD top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
GB:0A4DEquillium1.300.2928.46%
NRXPNRX Pharmaceuticals2.19-0.30-12.05%
STROSutro Biopharma9.820.778.53%
HYFTMindWalk Holdings0.99-0.69-41.07%
PRLDPrelude Therapeutics3.451.93126.97%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts